Skip to main content
  • Solutions
  • for Consumers
  • Stories
  • About us

  • Newsroom
  • Careers
  • Contact us
NewsroomCareersContact us
Newsroom /

Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program

Published

Thursday, October 1, 2026

Share

Invalid URL

Invalid URL

Invalid URL

Verily Pre will power CIRCLE’s shared database and AI-driven research tools to improve outcomes for critically ill patients

Dallas, TX – October 1, 2026 – Verily Health Inc., a precision health AI company, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to serve as an Acceleration Platform performer for the agency's Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE) program. In this role, Verily Health will build and operate the shared program database that CIRCLE's research teams will use to train, validate, and refine tools aimed at giving ICU care teams a real-time window into patients' immune systems.

ARPA-H recently announced the full slate of CIRCLE performers. CIRCLE is a five-year program working to give ICU clinicians real-time visibility into a patient's immune system so they can intervene before organ damage occurs. ARPA-H has set a program-wide goal of reducing average ICU length of stay by 25 percent.

"We're honored that ARPA-H selected Verily Health to build this program's data foundation. It reflects the trust federal researchers are placing in Verily Pre as a platform for complex, multi-institution science, and it's exactly the kind of opportunity that accelerates our vision to build a trusted foundation for healthcare," said Stephen Gillett, Chairman and CEO of Verily Health.

Verily Health's Role in CIRCLE
Verily Health was selected to build and operate the CIRCLE program database. Verily Workbench, part of the Verily Pre Platform, the company's flagship data and AI platform, will serve as the program’s secure database and research environment.

Verily Pre will ingest and harmonize public and private critical-illness datasets alongside data generated by the program's research teams for use in performer model training and validation. Verily Health will also generate data products intended to become resources for the broader critical care research community, giving researchers AI-powered search and discovery tools to explore the dataset rather than writing raw database queries.

This research was, in part, funded by the Advanced Research Projects Agency for Health (ARPA-H). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the United States Government.

About Verily Health Inc.
Verily Health is a data platform and technology company purpose-built to power AI-enabled precision health solutions that accelerate research and improve care for individuals and communities. Uniquely positioned at the intersection of technology, data science, and healthcare, Verily Health transforms multimodal health data into insights, models, and actions that make healthcare more personalized, predictive, and precise. For more information about Verily Health please visit: verily.com.

Contact us

Thank you for your interest in Verily. Please provide information below and we’ll be in touch shortly.

*Required fields

The information you provide will be used in accordance with our privacy policy.

Stay in the know. Subscribe to receive communications from Verily.

This email sign up is available for business email addresses for US users only.
  • Verily
  • Stories
  • About us
  • Resources
  • Contact
  • Publications
  • Newsroom
  • Press kit
  • Support
  • Security and Trust
  • Connect
  • X
  • LinkedIn
  • YouTube

  • © Verily Health | 2026
  • Accessibility
  • Code of Conduct
  • Verily Ethics Hotline
  • Privacy policy
  • Terms of use
  • Responsible supply chain
  • Your Privacy Choices
  • Consumer Health Data Privacy Policy

protected by reCAPTCHA